Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Low-Dose Thimerosal in Adults With Symptomatic SARS-CoV-2 Infection
NCT04522830Phase 2Completed
- Sponsor
- Beech Tree Labs
- Start
- Jul 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thimerosal in coronavirus disease 2019 (COVID-19), sponsored by Beech Tree Labs. Started Jul 2020; status: completed.
02
Drugs
thimerosal
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04522830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04522830.